{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:43:15Z","timestamp":1790055795143,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijrobp.2014.12.014","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T01:30:42Z","timestamp":1425259842000},"page":"745-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients"],"prefix":"10.1016","volume":"91","author":[{"given":"Andrea C.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. James","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Keyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Tyldesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.12.014_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00345-009-0418-9","article-title":"Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: A prospective study","volume":"27","author":"Giberti","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.brachy.2013.06.006","article-title":"Pride or prejudice: Does Phoenix flatter radiation therapy?","volume":"13","author":"Morris","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2013.10.010","article-title":"Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival","volume":"88","author":"Lo","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ijrobp.2014.12.014_bib5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2008.07.042","article-title":"Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate Cancer","volume":"73","author":"Morris","year":"2009","journal-title":"International Journal of Radiation OncologyBiologyPhysics"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/cncr.27911","article-title":"Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer","volume":"119","author":"Morris","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.urology.2008.07.064","article-title":"Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate Cancer","volume":"73","author":"Morris","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2009.07.1724","article-title":"Evaluating the Phoenix definition of biochemical failure after 125I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?","volume":"78","author":"Thompson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-Term Biochemical and Survival Outcome of 921 Patients Treated With I-125 Permanent Prostate Brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ijrobp.2014.12.014_bib11","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.brachy.2008.04.002","article-title":"Distant and local recurrence in patients with biochemical failure after prostate brachytherapy","volume":"7","author":"Stock","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0090-4295(94)90180-5","article-title":"Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases","volume":"43","author":"Partin","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2014.07.006","article-title":"Patterns of failure after iodine-125 seed implantation for prostate cancer","volume":"112","author":"Lamb","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijrobp.2014.12.014_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5489\/cuaj.11158","article-title":"The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia","volume":"6","author":"Tyldesley","year":"2012","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":"Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2014.12.014_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614044897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614044897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T08:30:41Z","timestamp":1566376241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614044897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0360301614044897"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}